Health · NZ ·

Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syn

FirstWord Pharma · Health

Published

Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syn

Read it at the source

FirstWord Pharma↗

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now